93
360° View
97
360° View
Our selection includes the stock peers with the best 360° View. See how they compare against Daiichi Sankyo.
|
Name
|
360° View
|
Sentiment
|
Combined
|
Value
|
Growth
|
Safety
|
|---|---|---|---|---|---|---|
|
1.
XL • Pharmaceuticals
|
97
|
14
|
20
|
14
|
67
|
45
|
|
2.
XL • Pharmaceuticals
|
93
|
14
|
20
|
14
|
67
|
45
|
|
3.
XL • Pharmaceuticals
|
64
|
14
|
20
|
14
|
67
|
45
|
|
4.
XL • Pharmaceuticals
|
93
|
14
|
20
|
14
|
67
|
45
|
|
5.
XL • Pharmaceuticals
|
91
|
14
|
20
|
14
|
67
|
45
|
|
6.
XL • Life Sciences Tools & Services
|
52
|
14
|
20
|
14
|
67
|
45
|
|
7.
XL • Pharmaceuticals
|
69
|
14
|
20
|
14
|
67
|
45
|
|
8.
XL • Life Sciences Tools & Services
|
76
|
14
|
20
|
14
|
67
|
45
|
|
9.
XL • Pharmaceuticals
|
30
|
14
|
20
|
14
|
67
|
45
|
|
10.
XL • Biotechnology
|
23
|
14
|
20
|
14
|
67
|
45
|
We compare Daiichi Sankyo against the Pharmaceuticals sector. Obermatt analyzes companies with similar market capitalizations and operational structures to ensure a fair comparison. Our goal is to help you find companies that may offer better Value, Growth, or Safety profiles than your current selection.
The list above displays the closest peers based on financial fundamentals. Review the "Combined Rank" to see which competitors are currently outperforming Daiichi Sankyo.
Daiichi Sankyo currently holds a 360° Rank of 93. Stocks with ranks above 50 are performing better than average. Compare this against the alternatives in the table above to make a data-driven decision.
The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
